Sign in / Join Now
ETFs & Funds
's a risky, high-ceiling play that has been talked a lot about. We think
is too risky, holding little upside to make it worth it.
Add a reply...
Latest StockTalks »
people get PDLI breaking news and analysis by email alert.
Get email alerts on PDLI »
PDL BioPharma, Inc.
Get latest price
From other sites
Short Interest In PDL BioPharma Declines 14.2%
at TheStreet (Sep 27, 2016)
Will PDL BioPharma (PDLI) Continue to Surge Higher?
at Zacks.com (Sep 20, 2016)
The Zacks Analyst Blog Highlights: Mylan, ANI Pharmaceuticals, Cambrex, PDL BioPharma and Innoviva
at Zacks.com (Sep 14, 2016)
PDL BioPharma Announces The Successful Conclusion Of Its Debt Financing Agreement With Paradigm Spine
at TheStreet (Aug 29, 2016)
Short Interest Moves 28% Lower For PDLI
at TheStreet (Aug 25, 2016)